Subscribe

Renegade
Neurologist
RSS Feed

Search

Wellness Health
Visit Our Sponsor »

Archive for the 'Children & Pregnancy' Category

New Clue to Milk and Diabetes Link?

From WebMD

The reaction of an infant’s immature immune system to a protein found in cow’s milk infant formula may explain the suspected link between early consumption of cow’s milk and an increased risk of developing type 1 diabetes later, according to a new study.

But experts who reviewed the study for WebMD say the research is mixed on the suspected link and the new report does not offer conclusive proof of cause and effect. While these experts strongly support breastfeeding, they say those mothers who can’t or choose not to breastfeed shouldn’t be alarmed by the report.

The Formula-Diabetes Theory

The protein under study, called beta-lactoglobulin, is found in cow’s milk but not human breast milk. It is similar in structure to the human protein glycodelin, writes Marcia F. Goldfarb, author of the new report.

The report is published in the letters section of the Journal of Proteome Research. Goldfarb directs Anatek-EP, a contract protein research laboratory in Portland, Maine.

An infant’s immature immune system may destroy the glycodelin in an effort to destroy the look-alike “foreign” protein beta-lactoglobulin, Goldfarb says.

Glycodelin controls the production of the body’s T-cells, which help protect against infection. If glycodelin is destroyed, there could be an overproduction of T cells, she says.

Share this Article:

Mailing List:


Dangerous Psych Drugs and Pregnancy: Help Stop the Mothers Act

From NaturalNews.com

The Senate is about to approve legislation Mothers Act

S.1375 (http://www.naturalnews.com/022853.html) which mandates the indoctrination of pregnant and nursing mothers into the use of extremely dangerous psychiatric medication. We already know this class of medication poses serious health risks to both mother and baby. Consequences to the baby are now proven to cause nerve-related changes that can adversely affect health for a lifetime.

This Big Pharma legislation was innocuously crafted under the pretense of helping pregnant mothers deal with stress and mood. On the surface it is made to look like a helpful public policy that any Senator would want to support. The reality is that pregnant and nursing mothers have become a Big Pharma target market and this legislation locks in taxpayer funds to dispense psych drugs to pregnant and nursing mothers

guaranteeing that Big Pharma will get billions for poisoning the most vulnerable members in our society.

Now that Senators are being called on the carpet for what this law will actually do; i.e., injure babies for life

they have gone behind close doors to finish marking up the bill and plan to sneak it through the Senate in the beginning of April without any debate or chance for amendment. A marriage of Big Pharma dollars with a bizarre socialist medicine agenda is more compelling to them than real health. The legislation is cosponsored by both Clinton and Obama (members of the Senate HELP committee that will bring the legislation to the floor of the Senate), but make no mistake

it is also widely supported by republican senators and Bush will sign it in a heartbeat. Both sides of the aisle are owned by Big Pharma. The only thing more important to them than the Big Pharma money is their image

so let’s make it clear: they are proposing legislation that knowingly will injure mothers and babies.

The only thing standing in the way of the final passage of this legislation is your opposition. Go to my website at www.wellnessresources.com and click on the Take Action link. With two mouse clicks you can use my CapWiz software to send a letter of opposition to both of your senators, it only takes 30 seconds.

Scientific Evidence of Psych-Drug Damage Relating to Pregnancy

The dangers of psych drugs during pregnancy and lactation have been reported for a number of years. However, within the past six months a stunning amount of new data has become available which I will now summarize for you. A lot of this information is new since the Senate bill was first crafted. Any Senator who was truly interested in the health and well being of mother and child would put the Mothers Act on hold until the true risks of these drugs are fully known. It is completely irresponsible of Senators to create laws which will directly injure mothers, unborn children, and new babies.

It is a well known scientific fact that psych drugs readily cross the placenta and expose the fetus to pharmacologically active levels of these drugs. It is also known that nursing mothers have pharmacologically active levels of these drugs in their breast milk.

Exposing a fetus or new baby to these drugs is far different than exposing the adult nervous system which has already established brain circuitry. The fetus’s evolving nerves are trying to form core nerve circuitry (like computer hardware) that cannot easily be changed later, establishing connections throughout the body

such as to the heart and lungs, and setting up how these organs will be run by the nerves over the course of a lifetime. Available evidence clearly shows that psych drugs interfere with these natural processes and pose a grave risk to the unborn

a risk that can result in a lifetime of poor health.

A meta-analysis published in May of 2007 ((http://www.ncbi.nlm.nih.gov/pubmed/1769…) showed that women taking antidepressants in the first trimester of pregnancy had a 72% increased risk for a child with cardiac malformation (birth defect). A study published in Dec of 2006 ((http://www.ncbi.nlm.nih.gov/pubmed/1716…) reviewed earlier studies showing that the use of antidepressants during any phase of pregnancy carried serious risks for birth defects, especially cardiovascular.

It reviewed a Danish study showing 60% increased risk, an American study showing 100% increased risk, and a Swedish study showing 120% increased risk for cardiovascular defects. The American study showed 4% of women who used antidepressants during pregnancy had a baby with any type of birth defect; 2% of women having babies with cardiovascular birth defects. It is clear that antidepressant medication interferes with how nerves communicate to the heart as the fetus is evolving. The story of Manie

a baby born with an antidepressant-induced heart defect can be found at http://www.uniteforlife.org/.

A Dec of 2007 Dutch study ((http://www.ncbi.nlm.nih.gov/pubmed/1825…) reports on the broad array of side effects in babies whose mothers took antidepressants during pregnancy. These include respiratory distress, feeding and digestive disturbances, irritability, and convulsions. The authors also point out that animal studies have shown “permanent changes in specific parts of the brain and altered behavior in adulthood after perinatal exposure to SSRIs.”

A Dec of 2007 Swedish study ((http://www.ncbi.nlm.nih.gov/pubmed/1800…) confirms much of this information, again pointing out the high rates of respiratory distress, convulsions, hypoglycemia, and overall poor health (low Apgar scores). An Oct of 2006 study ((http://www.ncbi.nlm.nih.gov/pubmed/1692…) explains that 30% of babies born to mothers who used antidepressants have significant inability to adapt (adjusting to being born and then thriving). This means that even when there are not blatant birth defects, general health of the newborn is compromised across the boards

an incredibly dangerous situation.

Indeed, data published in Oct of 2006 ((http://www.ncbi.nlm.nih.gov/pubmed/1689…) showed mothers who took antidepressants are much more likely to have premature deliveries and low birth weight babies

indicative of general malnutrition induced by antidepressant medication. Studies in sheep ((http://www.ncbi.nlm.nih.gov/pubmed/1626…) clearly show that this is because antidepressants reduce the flow of blood to the uterus, in turn reducing the amount of oxygen and nutrition that can get to the baby.

An Oct of 2007 U.S. study ((http://www.ncbi.nlm.nih.gov/pubmed/1770…) reviewed the animal data that shows exposure to antidepressants causes life long abnormalities in behavior and stress tolerance. A Feb of 2005 study ((http://www.ncbi.nlm.nih.gov/pubmed/1568…) demonstrated that 2 month old infants already had a depressed and inappropriate response to pain

a key factor indicating disturbed development of the nervous system.

This issue is directly related to properly coping with stress or pain as an adult, the failure of which leads to anxiety, fibromyalgia, and increased risk for sudden death from a cardiovascular event. This is a profound neurologic change because it means that the developing nervous system, as a result of exposure to psych meds, has been “traumatized,” adversely priming nerves to hyper-react to future stress.

Several studies have tried to identify childhood behavioral and attention issues in those exposed to psych drugs during pregnancy (Jan of 2007: http://www.ncbi.nlm.nih.gov/pubmed/1719… and June of 2006: http://www.ncbi.nlm.nih.gov/pubmed/1674…). While poor coping trends are evident, a clear pattern has not emerged because these children are still living in high stress environments due to parental instability

which is never good for children whether they have been exposed to medication or not.

The bottom line of all of this information about psych drug use during pregnancy is that it is one huge experiment with many unknown and likely adverse health consequences. Once again we see the failure of the FDA to protect the public, as the FDA does not demand Big Pharma do studies to prove these drugs are safe for pregnant women. To the contrary, most available science tilts in the direction that they are quite unsafe and carry extreme risks for the baby

with ominous implications for future poor health for the child and health care costs to society.

Senators in favor of this legislation, which would steer 80% of pregnant women on to these meds, need their heads and morality examined. They should be personally held accountable to the mothers whose babies their law injures.

Share this Article:

Mailing List:


Babies gain weight with less sleep -

From USATODAY.com

Infants and toddlers who slept fewer than 12 hours in a 24-hour period were twice as likely to be overweight than longer sleepers by the time they’re 3 years old, a study showed Monday.

The children most likely to be overweight were those who slept less than 12 hours and watched at least two hours of television a day, says the study in the Archives of Pediatric and Adolescent Medicine.

 

BETTER LIFE: TV time matters, too

Although previous research has linked inadequate sleep with weight gain in adults and older children and TV viewing and obesity in older children, the authors of the new study say theirs is the first to connect sleep and television viewing in infants to excess weight.

The researchers focused on 915 children in an ongoing Massachusetts study. When the children were 6 months old, their mothers were asked about their sleeping habits. When the children were ages 1 and 2, the mothers were asked about their sleep and television watching.

“One of the things we thought was that if children are sleeping less they might be watching more TV, and maybe that would explain the relationship between sleep and obesity,” says lead author Elsie Taveras, a Harvard pediatrician who runs the childhood obesity prevention clinic at Children’s Hospital Boston. “But that wasn’t the case.”

The children slept an average of 12.3 hours a day at age 6 months, 12.8 hours a day at 1 year and 12 hours a day at age 2. Some who slept more than 12 hours also watched more than two hours of TV a day, while some briefer sleepers didn’t.

Why less sleep in infancy and toddlerhood was linked to a greater chance of becoming overweight isn’t clear, says co-author Matthew Gillman, also a Harvard pediatrician. Gillman says some short-term experiments in adults suggest that “people whose sleep is curtailed do have hormone changes that tend to increase appetite.”

Share this Article:

Mailing List:


Fetal Exposure to Substance Abuse Changes Brain Structure

Mom’s use of tobacco, alcohol, drugs may affect kids into early adolescence, study shows

From HealthDay

Babies born to women who use cocaine, alcohol or tobacco during pregnancy may have brain structure changes that persist into early adolescence, a new U.S. study says.

Researchers at Children’s Hospital Boston and the Boston Medical Center used MRI scans to study the brains of 35 children, average age 12, who were exposed to the substances while in the womb.

“We found that reductions in cortical gray matter and total brain volumes were associated with prenatal exposure to cocaine, alcohol or cigarettes,” study first author Dr. Michael Rivkin, a neurologist at Children’s Hospital Boston, said in a prepared statement.

The more substances a child was exposed to, the greater the reduction in brain volume.

The study, published in the April issue of the journal Pediatrics, is the first to document joint long-term effects of prenatal cocaine, alcohol and tobacco exposure on brain structure, Rivkin said.

Previous studies that documented brain effects of prenatal alcohol exposure were mostly limited to children with fetal alcohol syndrome. Children with that condition were excluded from this new study.

Rivkin noted that his study was too small to find statistically significant effects of single substances after factoring in exposure to other substances, and was also too small to document the effects of different levels of prenatal exposure.

However, Rivkin said the overall findings are highly suggestive, and he and his colleagues would like to continue their research into this important public health matter. It’s estimated that more than one million babies born each year in the United States have been exposed to at least one of these substance while in the womb.

Health-care providers should offer pregnant women comprehensive care to help them reduce the use of all harmful substances. And public health campaigns shouldn’t ignore the risks of some substances while focusing on others, since the greater the number of total prenatal exposures, the more likely there will be harmful and lasting effects on a baby’s developing brain, the study authors said.

Share this Article:

Mailing List:


Study: Magnesium sulfate cuts risk of CP in preemies

From USATODAY.com

Giving a cheap and widely available drug to pregnant women at high risk of premature delivery cut the risk of cerebral palsy in their babies by nearly half, according to a study presented Thursday.

Premature babies are at high risk for cerebral palsy, an often devastating movement disorder caused by brain damage before, during or after birth, says study co-author John Thorp, a professor at the University of North Carolina at Chapel Hill. About one-third of cerebral palsy cases are caused by early preterm birth, he says.

Giving magnesium sulfate, or Epsom salt, could save many children from the condition, Thorp says. Doctors regularly use the drug to halt contractions when women go into labor very early. The drug is found in virtually every labor and delivery department and costs just pennies a dose, he says.

In Thorp’s study, presented at the Society for Maternal-Fetal Medicine annual meeting in Dallas, doctors focused on 2,241 women whose water broke very early

between the 24th and 31st weeks of pregnancy. A full-term delivery occurs after at least 37 weeks.

Doctors randomly assigned some women to get intravenous magnesium sulfate and others to get a placebo, a study design that’s considered the “gold standard” of medical testing.

About 1.9% of women on magnesium sulfate had babies with moderate or severe cerebral palsy, compared to 3.5% of women who didn’t get the drug, the study shows. The drug caused no serious side effects, although more women taking magnesium sulfate felt flushed or sweaty. Some reported temporarily blurred vision.

“This is a real breakthrough,” says Thorp, noting that his study is especially powerful because it confirms the findings of a 2003 Australian study. “These are children who have their whole lives in front of them.”

About 2 or 3 children in 1,000 over the age of 3 are diagnosed with cerebral palsy every year, says Dara Richardson-Heron, national medical director of United Cerebral Palsy, which wasn’t involved in the study. She called the study “very promising.”

Margarita de Veciana, a maternal-fetal medicine specialist at Eastern Virginia Medical School in Norfolk, Va., says Thorp’s study is likely to spark a debate.

Some doctors are now using drugs other than magnesium sulfate to prevent preterm labor, de Veciana says, because studies haven’t shown that magnesium sulfate works as well as previously believed. Doctors may reconsider abandoning magnesium sulfate, however, if it can prevent disabilities.

“This could have a huge impact,” de Veciana says.

Geeta Swamy, a maternal-fetal medicine specialist and assistant professor at Duke University Medical Center, says Thorp’s study isn’t likely to change the way women are treated right away.

Although the drug caused no serious problems in Thorp’s study, Swamy says a handful of women each year do have bad reactions to magnesium sulfate, which can sometimes cause respiratory problems. Doctors will want to scrutinize Thorp’s data to decide if the drug’s benefits outweigh its risks.

“This study has the potential to change practice, but we don’t have enough information yet,” Swamy says.

Share this Article:

Mailing List: